Search research articles
Contact Us
Filters
Showing results (111-120 of 177) with videos related to
Page
of 18
Sort By:
Blood
|
February 26, 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia
Andreas Linder, Daniel Nixdorf, Niklas Kuhl, et al.
Cancer Immunology, Immunotherapy : CII
|
May 8, 2023
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Journal for Immunotherapy of Cancer
|
November 26, 2021
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1
Abbass Darwich, Alessandra Silvestri, Mohamed-Reda Benmebarek, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 21, 2019
Advances in cancer immunotherapy 2019 - latest trends
Stephan Kruger, Matthias Ilmer, Sebastian Kobold, et al.
Cancer Immunology, Immunotherapy : CII
|
April 11, 2023
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Frontiers in Immunology
|
December 4, 2023
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
Hanna F Nowotny, Thomas Marchant Seiter, Jing Ju, et al.
Blood Cancer Journal
|
June 5, 2021
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins
Franziska Blaeschke, Dana Stenger, Antonia Apfelbeck, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2024
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma
Sophia Stock, Luisa Fertig, Adrian Gottschlich, et al.
Biological Chemistry
|
January 24, 2022
Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies
Steffen Dickopf, Can Buldun, Vedran Vasic, et al.
Biomedicines
|
March 25, 2022
An In Vivo Inflammatory Loop Potentiates KRAS Blockade
Kristina A M Arendt, Giannoula Ntaliarda, Vasileios Armenis, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 177) with videos related to
Sort By:
Page
of 18
Blood
|
February 26, 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia
Andreas Linder, Daniel Nixdorf, Niklas Kuhl, et al.
Cancer Immunology, Immunotherapy : CII
|
May 8, 2023
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Journal for Immunotherapy of Cancer
|
November 26, 2021
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1
Abbass Darwich, Alessandra Silvestri, Mohamed-Reda Benmebarek, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 21, 2019
Advances in cancer immunotherapy 2019 - latest trends
Stephan Kruger, Matthias Ilmer, Sebastian Kobold, et al.
Cancer Immunology, Immunotherapy : CII
|
April 11, 2023
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Anetta Marcinek, Bettina Brauchle, Lisa Rohrbacher, et al.
Frontiers in Immunology
|
December 4, 2023
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
Hanna F Nowotny, Thomas Marchant Seiter, Jing Ju, et al.
Blood Cancer Journal
|
June 5, 2021
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins
Franziska Blaeschke, Dana Stenger, Antonia Apfelbeck, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2024
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma
Sophia Stock, Luisa Fertig, Adrian Gottschlich, et al.
Biological Chemistry
|
January 24, 2022
Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies
Steffen Dickopf, Can Buldun, Vedran Vasic, et al.
Biomedicines
|
March 25, 2022
An In Vivo Inflammatory Loop Potentiates KRAS Blockade
Kristina A M Arendt, Giannoula Ntaliarda, Vasileios Armenis, et al.
Page
of 18